0.65
+0.0455(+7.47%)
Currency In USD
| Previous Close | 0.61 |
| Open | 0.62 |
| Day High | 0.67 |
| Day Low | 0.6 |
| 52-Week High | 9.56 |
| 52-Week Low | 0.31 |
| Volume | 1.61M |
| Average Volume | 6.51M |
| Market Cap | 10.57M |
| PE | -0.28 |
| EPS | -2.34 |
| Moving Average 50 Days | 0.99 |
| Moving Average 200 Days | 1.97 |
| Change | 0.05 |
If you invested $1000 in SeaStar Medical Holding Corporation (ICU) since IPO date, it would be worth $1.04M as of July 17, 2025 at a share price of $0.655. Whereas If you bought $1000 worth of SeaStar Medical Holding Corporation (ICU) shares 3 years ago, it would be worth $1M as of July 17, 2025 at a share price of $0.655.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry
GlobeNewswire Inc.
Yesterday at 12:45 PM GMT
Highest Rated Children’s Medical Centers Now Employ QUELIMMUNE for Ultra-Rare Cases of Pediatric AKI HDE Surveillance Registry Data Captures Key Metrics for Future Analysis of QUELIMMUNE Performance DENVER, July 16, 2025 (GLOBE NEWSWIRE) -- SeaSta
SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.
Jul 10, 2025 7:29 PM GMT
DENVER, July 10, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, today
SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)
GlobeNewswire Inc.
Jul 08, 2025 12:05 PM GMT
Nationally Recognized Texas Children’s Hospital Adds First-In-Class Therapy as a Potential Life-Saving Treatment in Ultra-Rare Cases of Pediatric AKIDENVER, July 08, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a comm